论文部分内容阅读
目的观察洛伐他汀治疗72例高血脂症的临床疗效与安全性。方法选择144例高血脂症患者,随机分为观察组与对照组,各72例。观察组采用洛伐他汀治疗,对照组不采用药物治疗。结果观察组总有效率88.9%,观察组TC、TG、LDL-C、LDL/HDL治疗后与治疗前及对照组相比,差异有统计学意义(P<0.05),所有患者在治疗过程中均无明显的毒副作用。结论洛伐他汀治疗高血脂症具有良好的疗效与安全性。
Objective To observe the clinical efficacy and safety of lovastatin in treating 72 cases of hyperlipidemia. Methods 144 cases of hyperlipidemia were randomly divided into observation group and control group with 72 cases in each group. The observation group treated with lovastatin, the control group without medication. Results The total effective rate in the observation group was 88.9%. There was significant difference (P <0.05) between TC, TG, LDL-C and LDL / HDL after treatment in the observation group and in the control group No obvious side effects. Conclusion Lovastatin treatment of hyperlipidemia has good efficacy and safety.